Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,094,508
-$269,112 QoQ
Shares Held
45,453
-6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#1,278
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHULHOFF & CO INC holds $28,075,111 across 8 Drug Manufacturers - General names. PFE ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,998 | $10,412,262 | |
| 2 | ABBV |
AbbVie Inc.
|
26,880 | $6,764,083 | |
| 3 | LLY |
ELI LILLY & Co
|
4,825 | $5,787,250 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,263 | $1,575,795 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,914 | $1,205,064 | |
| 6 | PFE |
Pfizer Inc
This page
|
45,453 | $1,094,508 | |
| 7 | NVS |
Novartis AG
|
6,053 | $948,626 | |
| 8 | AMGN |
Amgen Inc
|
794 | $287,523 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,094,508 | 45,453 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,363,620 | 48,562 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,207,699 | 48,502 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,260,546 | 49,472 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,197,722 | 49,411 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,170,657 | 46,198 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,241,604 | 46,800 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,485,663 | 51,336 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,656,080 | 59,188 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,646,851 | 59,346 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,707,131 | 59,296 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,879,379 | 56,659 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,094,978 | 57,115 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $2,326,864 | 57,031 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,920,680 | 57,000 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,607,220 | 59,580 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,122,573 | 59,557 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,087,614 | 59,641 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $3,529,536 | 59,772 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,589,072 | 60,197 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,357,197 | 60,194 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,174,017 | 60,006 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $2,185,777 | 59,380 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,183,904 | 59,507 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $1,921,748 | 58,769 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $1,917,434 | 58,745 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||